BIOS VS CPSS Stock Comparison
Performance
BIOS100/100
100/100
BIOS returned 7.25% in the last 12 months. Based on SPY's performance of -3.02%, its performance is above average giving it a score of 100 of 100.
CPSS100/100
100/100
CPSS returned 24.66% in the last 12 months. Based on SPY's performance of -1.87%, its performance is above average giving it a score of 100 of 100.
Analyst Price Targets
BIOS88/100
88/100
6 analysts offer 12-month price targets for BIOS. Together, they have an average target of 0, the most optimistic target put BIOS at 0 within 12-months and the most pessimistic has BIOS at 0. These analyst ratings are from our partners at Financial Modeling Prep and Alpha Vantage.
CPSS63/100
63/100
4 analysts offer 12-month price targets for CPSS. Together, they have an average target of 0, the most optimistic target put CPSS at 0 within 12-months and the most pessimistic has CPSS at 0.
Profit
BIOS12/100
12/100
Out of the last 20 quarters, BIOS has had 4 profitable quarters and has increased their profits year over year on 0 of them.
CPSS86/100
86/100
Out of the last 20 quarters, CPSS has had 20 profitable quarters and has increased their profits year over year on 10 of them.
Volatility
BIOS10/100
10/100
BIOS has had a lower than average amount of volatility over the last 12 months giving it a score of 10 of 100.
CPSS53/100
53/100
CPSS has had a higher than average amount of volatility over the last 12 months giving it a score of 53 of 100.
Sentiment
BIOS
"Sentiment" not found for BIOS
CPSS68/100
68/100
CPSS had a bullish sentiment score of 67.56% across Twitter and StockTwits over the last 12 months. It had an average of 3.00 posts, 0.00 comments, and 0.00 likes per day.
Technicals
BIOS
"Technicals" not found for BIOS
CPSS79/100
79/100
CPSS receives a 78 of 100 based on 14 indicators. 10 are bullish, 2 are bearish.
Earnings
BIOS
"Earnings" not found for BIOS
CPSS10/100
10/100
CPSS has missed earnings 6 times in the last 20 quarters.
All score calculations are broken down here to help you make more informed investing decisions
BioPlus Acquisition Corp. Class A Ordinary Shares Summary
Nasdaq / BIOS
Financial Services
Shell Companies
BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.
Consumer Portfolio Services Summary
Nasdaq / CPSS
Financial Services
Financial - Credit Services
Consumer Portfolio Services, Inc. operates as a specialty finance company in the United States. It is involved in the purchase and service of retail automobile contracts originated by franchised automobile dealers and select independent dealers in the sale of new and used automobiles, light trucks, and passenger vans. The company, through its automobile contract purchases, offers indirect financing to the customers of dealers with limited credit histories or past credit problems. It serves as an alternative source of financing for dealers, facilitating sales to customers who are not able to obtain financing from commercial banks, credit unions, and the captive finance companies. The company also acquires installment purchase contracts in four merger and acquisition transactions; purchases immaterial amounts of vehicle purchase money loans from non-affiliated lenders. and offers financing directly to sub-prime consumers to facilitate their purchase of a new or used automobile, light truck, or passenger van. It services its automobile contracts through its branches in California, Nevada, Virginia, Florida, and Illinois. The company was founded in 1991 and is based in Las Vegas, Nevada.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Compare Similar Companies
Compare BIOS to other companies in the same or a similar industry.